The Food and Drug Administration has approved the (PPD) which is suffered by around one in seven new mothers. Zuranolone, which is an antidepressant, is a once-a-day pill, taken for two weeks. It will be sold under the brand name Zurzuvae.Clinical trials showed it improved the symptoms of new mothers who were experiencing severe after having a baby.
Load More
Load More